09 July 2025  |  In this episode, Bart van Wezenbeek and Tilman Pfrang talk about second medical use patents. They explore how the UPC handled novelty and inventive step without the EPO’s traditional PSA, and what it means for proving infringement under a purpose-limited claim. Finally, they flag the high stakes, cost caps, and the likely appeal that could set future UPC precedent.Credits:Host: Sam PittisProduced by WHS LearningMusic used in this episode: Listen by Andrewkn -- https://shorturl.at/ekqz1 -- License: Creative Commons 0, Road In The Forest by Andrewkn -- https://shorturl.at/jrJT8 -- License: Creative Commons 0, Dunes by Andrewkn -- https://shorturl.at/noG35 -- License: Creative Commons 0Musical Ambient - I (Piano).wav by GregorQuendel -- https://freesound.org/s/697879/ -- License: Attribution NonCommercial 4.0 Disclaimer: The views expressed are solely those of the podcast participants and may not reflect the opinions of epi or the guest speakers' organisations.

Ver todos los episodios